A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 Years
Clinical trial NCT05991427 · COMPLETED
Trial details
- NCT number
- NCT05991427
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2024-11-04
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.